Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

rBet

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Combining allergen(s) with an adjuvant is a strategy to improve the efficacy and safety of allergen‐specific immunotherapy. Here… Expand
Is this relevant?
2010
2010
BACKGROUND At least 100 million patients suffer from birch pollen allergy. OBJECTIVE Rational design of recombinant derivatives… Expand
Is this relevant?
2010
2010
BACKGROUND Persons allergic to birch pollen often report oral and pharyngeal hypersensitivity to fruit and vegetables, such as… Expand
Is this relevant?
2008
2008
BACKGROUND/AIM Oral allergy syndrome (OAS) to plant foods is often caused by cross-reactivity to pollen. We investigated whether… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Background Genetic engineering of the major birch pollen allergen (Bet v 1) has led to the generation of recombinant Bet v 1… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND Pollen from trees of the order Fagales are important allergen sources in most parts of the world. Clinical… Expand
Is this relevant?
1997
1997
There are differences in IgE reactivity to rBet v 1 and rBet v 2 among allergic patients from the six countries studied. The… Expand
Is this relevant?
1997
1997
Modulation of allergic immune responses by using adequate adjuvants is a promising concept for future immunotherapy of type I… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
1996
1996
BACKGROUND Serologic measurements with recombinant birch pollen allergens, rBet v 1 and rBet v 2 (birch profilin), have shown… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
OBJECTIVE This study assesses the value of two recombinant birch allergens for diagnosis of patients sensitized to birch pollen… Expand
Is this relevant?